InvestorsHub Logo
Followers 35
Posts 6924
Boards Moderated 1
Alias Born 04/04/2020

Re: Gusman post# 365957

Monday, 01/10/2022 11:05:53 AM

Monday, January 10, 2022 11:05:53 AM

Post# of 427280
Gusman, I think Amarin ran studies using Vascepa paired with Atrovastin.(Lipator) That is from memory. If I'm wrong someone correct me. We have approval for adjunct therapy. I don't know what FDA will require for combination therapy. I will try to find out.
Sleven,
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News